The International Neuroethics Society (INS) is a professional organization that studies the social, legal, ethical, and policy implications of advances in neuroscience. Its mission is to encourage and inspire research and dialogue on the responsible use of advances in brain science. [1] The current INS President is Joseph J. Fins, MD. [2]
The INS was formed as the Neuroethics Society in May 2006 in Asilomar, California by a multidisciplinary group of 13 members, including neuroscientists, psychologists, philosophers, bioethicists and lawyers. [3] [4] [5] This group formed the INS following the first meeting solely devoted to neuroethics held in San Francisco in 2002, entitled 'Neuroethics: Mapping the Field'. This meeting was co-hosted by Stanford University and the University of California, San Francisco (UCSF), and sponsored by the Dana Foundation. [6] This event prompted the attending and future founders of the INS to meet again and discuss the creation of a society devoted to neuroethics. The formation of the Neuroethics Society was formally announced in July 2006. [7]
The founding president of the INS was Professor Steven Hyman, who served as president from 2006 to 2014. [4] [8] Hyman stated that the role of the Society was to study the issues related to the nervous system that are not neatly contained within traditional bioethics, as well as to bridge the gap between advances in neuroscience and the world of policy and ethics. [9]
The Neuroethics Society was renamed the International Neuroethics Society in 2011, prior to the Society's 2011 Annual Meeting, to reflect its international membership and mission. [10]
The official journal of the INS is the American Journal of Bioethics-Neuroscience (AJOB-Neuroscience), which has Paul Root Wolpe as its Editor-in-Chief. [11] [12] The journal launched in 2007 as a section of the American Journal of Bioethics and became an independent journal in 2010, publishing four issues a year. [13]
Past Presidents of the Society include: Nita Farahany (2019–2021), Hank Greely (2017–2019), Judy Illes (2016–2017), Barbara Sahakian (2014–2016), and Steven Hyman (2008–2014). [14]
The INS is an international organisation, with over 300 members. [15] Membership is open to anyone with an interest in neuroethics, including students, for whom there is a discounted rate. [16]
The INS is a non-profit organisation and was formed by a grant from the Dana Foundation. [4] [7] The society has its headquarters in Bethesda, Maryland, USA. [17]
In May 2007, the INS sponsored a forum on the ethics of neuroenhancement in Washington, D.C., which was hosted by the Dana Foundation. This was followed by the first annual meeting of the INS in 2008, also held in Washington, DC. [18] This 2-day meeting was held prior to the Society for Neuroscience (SfN) annual conference was attended by over 200 people. [19] [20]
Since 2010, the INS has continuously held a meeting annually as a satellite of the Society for Neuroscience conference. [21] In addition to plenary speakers, panel discussions, networking and mentoring sessions, researchers are invited to present posters of their work. The dates, locations, themes and program information for past INS annual meetings are as follows: [22]
Year | Dates | Location | Theme | Reference |
---|---|---|---|---|
2008 | November 14–15 | Washington, DC, USA | [18] | |
2010 | November 11–12 | San Diego, CA, USA | [23] | |
2011 | November 10–11 | Washington, DC, USA | [24] | |
2012 | November 11–12 | New Orleans, LA, USA | [10] | |
2013 | November 7–8 | San Diego, CA, USA | [25] | |
2014 | November 13–14 | Washington, DC, USA | [26] | |
2015 | October 15–16 | Chicago, IL, USA | [27] | |
2016 | November 10–11 | San Diego, CA, USA | [28] | |
2017 | November 9–10 | Washington, DC, USA | Honoring our History, Forging our Future | [29] |
2018 | November 1–2 | San Diego, CA, USA | Cutting Edge Neuroscience, Cutting Edge Neuroethics | [30] |
2019 | October 17–18 | Chicago, IL, USA | Mapping Neuroethics: An Expanded Vision | [31] |
In addition to the Annual Meeting, the INS collaborates with other organizations in programs on neuroethics and related topics each year, including events at the Federation of European Neuroscience Societies (FENS) and the British Neuroscience Association. [32]
In 2014, the Presidential Commission for the Study of Bioethical Issues, which advises the President of the United States on bioethical issues arising from advances in biomedicine and related areas of science and technology, asked for public comment on the ethical considerations of neuroscience research and the application of neuroscience research findings. [33] [34] In response, the INS listed the top 12 areas of importance for consideration by the commission, which were published in the Journal of Law and the Biosciences. The INS detailed the top 5 important areas that will have an ethical impact on society as the Human Brain Projects (both the UK and USA versions), human enhancement (the use of 'smart drugs' by healthy people), neurotechnology, responsibility and the law and mental health and brain disorders. [15] Members of the Presidential Commission attended the INS Annual Meeting in November 2014 to further discuss the ethical issues surrounding neuroscience research. [35]
Neuroscience is the scientific study of the nervous system, its functions and disorders. It is a multidisciplinary science that combines physiology, anatomy, molecular biology, developmental biology, cytology, psychology, physics, computer science, chemistry, medicine, statistics, and mathematical modeling to understand the fundamental and emergent properties of neurons, glia and neural circuits. The understanding of the biological basis of learning, memory, behavior, perception, and consciousness has been described by Eric Kandel as the "epic challenge" of the biological sciences.
In philosophy and neuroscience, neuroethics is the study of both the ethics of neuroscience and the neuroscience of ethics. The ethics of neuroscience concerns the ethical, legal and social impact of neuroscience, including the ways in which neurotechnology can be used to predict or alter human behavior and "the implications of our mechanistic understanding of brain function for society... integrating neuroscientific knowledge with ethical and social thought".
The Dana Foundation is a private philanthropic organization based in New York dedicated to advancing neuroscience and society by supporting cross-disciplinary intersections such as neuroscience and ethics, law, policy, humanities, and arts.
Martha Julia Farah is a cognitive neuroscience researcher at the University of Pennsylvania. She has worked on an unusually wide range of topics; the citation for her lifetime achievement award from the Association for Psychological Science states that “Her studies on the topics of mental imagery, face recognition, semantic memory, reading, attention, and executive functioning have become classics in the field.”
Joseph J. Fins, M.D., D. Hum. Litt., M.A.C.P., F.R.C.P. is an American physician and medical ethicist. He is chief of the Division of Medical Ethics at New York Presbyterian Hospital and Weill Cornell Medical College, where he serves as The E. William Davis Jr., M.D. Professor of Medical Ethics, and Professor of Medicine, Professor of Public Health, and Professor of Medicine in Psychiatry. Fins is also Director of Medical Ethics and an attending physician at New York Presbyterian Hospital-Weill Cornell Medical Center. Fins is also a member of the adjunct faculty of Rockefeller University and has served as Associate for Medicine at The Hastings Center. He is the Solomon Center Distinguished Scholar in Medicine, Bioethics and the Law and a Visiting Professor of Law at Yale Law School. He was appointed by President Bill Clinton to The White House Commission on Complementary and Alternative Medicine Policy and currently serves on The New York State Task Force on Life and the Law by gubernatorial appointment.
The Decade of the Brain was a designation for 1990–1999 by U.S. president George H. W. Bush as part of a larger effort involving the Library of Congress and the National Institute of Mental Health of the National Institutes of Health "to enhance public awareness of the benefits to be derived from brain research".
Helen S. Mayberg was born in 1956 in California. She is an American neurologist. Mayberg is known in particular for her work delineating abnormal brain function in patients with major depression using functional neuroimaging. This work led to the first pilot study of deep brain stimulation (DBS), a reversible method of selective modulation of a specific brain circuit, for patients with treatment-resistant depression. As of August 2019, she has published 211 original peer-reviewed articles, 31 books and book chapters, and acted as principal investigator on 24 research grants. Mayberg is coinventor with Andres Lozano of “Method for Treating Depression Mood Disorders and Anxiety Disorders using Neuromodulation,” US patent 2005/0033379A1. St. Jude Medical Neuromodulation licensed her intellectual property to develop Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Unipolar and Bipolar Depression for the treatment of severe depression. As of 2018, Mayberg holds positions as Professor of Neurology and Neurosurgery and Professor, Psychiatry and Neuroscience, both at Mount Sinai Medical School, and Professor of Psychiatry, Emory University; Emory University Hospital. Since 2018, she has served as Director, Nash Family Center for Advanced Circuit Therapeutics at the Icahn School of Medicine at Mount Sinai.
Ethics or moral philosophy is a branch of philosophy that involves systematizing, defending, and recommending concepts of right and wrong conduct. The field of ethics, along with aesthetics, concern matters of value, and thus comprise the branch of philosophy called axiology.
Jonathan D. Moreno is an American philosopher and historian who specializes in the intersection of bioethics, culture, science, and national security, and has published seminal works on the history, sociology and politics of biology and medicine. He is an elected member of the National Academy of Medicine.
Steven Edward Hyman is Director of the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard in Cambridge, Massachusetts. He is also Harvard University Distinguished Service Professor of Stem Cell and Regenerative Biology. Hyman was Provost of Harvard University from 2001 to 2011 and before that Director of the U.S. National Institute of Mental Health (NIMH) from 1996 to 2001. Hyman received the 2016 Rhoda and Bernard Sarnat International Prize in Mental Health from the National Academy of Medicine for "leadership in furthering understanding and treatment of psychiatric disorders as biological diseases".
The National Core for Neuroethics at the University of British Columbia was established in August 2007, with support from the Canadian Institutes of Health Research, the Institute of Mental Health and Addiction, the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, the Canada Research Chairs program, the UBC Brain Research Centre and the UBC Institute of Mental Health. Co-founded by Judy Illes and Peter Reiner, the Core studies neuroethics, with particular focus on ethics in neurodegenerative disease and regenerative medicine, international and cross-cultural challenges in brain research, neuroimaging and ethics, the neuroethics of enhancement, and personalized medicine.
Judy Illes,, PHD, FRSC, FCAHS, is Professor of Neurology and Distinguished University Scholar in Neuroethics at the University of British Columbia. She is Director of Neuroethics Canada at UBC, and faculty in the Brain Research Centre at UBC and at the Vancouver Coastal Health Research Institute. She also holds affiliate appointments in the School of Population and Public Health and the School of Journalism at UBC, and in the Department of Computer Science and Engineering at the University of Washington in Seattle, WA. USA. She was appointed a member of the Order of Canada in 2017.
The Presidential Commission for the Study of Bioethical Issues was created by Executive Order 13521 on November 24, 2009. The Bioethics Commission advised President Barack Obama on bioethical issues arising from advances in biomedicine and related areas of science and technology. It replaced The President's Council on Bioethics appointed by United States President George W. Bush to advise his administration on bioethics, and the National Bioethics Advisory Commission (1996-2001). No national organization replaced it when its authorization expired; it "held its final meeting at the end of August 2016 and closed its doors."
Anjan Chatterjee is a professor of neurology at the Perelman School of Medicine at the University of Pennsylvania. He is director of the Penn Center for Neuroaesthetics (PCfN) and a member of the Center for Cognitive Neuroscience. His research focuses on spatial cognition and its relationship to language. He also conducts neuroaesthetics research and writes about the ethical use of neuroscience findings in society.
Barbara Jacquelyn Sahakian, is professor of clinical neuropsychology at the department of psychiatry and Medical Research Council (MRC)/Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge. She is also an honorary clinical psychologist at Addenbrooke's Hospital, Cambridge. She has an international reputation in the fields of cognitive psychopharmacology, neuroethics, neuropsychology, neuropsychiatry and neuroimaging.
Rebecca M. Jordan-Young, is an American feminist scientist and gender studies scholar. Her research focuses on social medical science, sex, gender, sexuality, and epidemiology. She is an Associate Professor of Women’s, Gender, and Sexuality Studies at Barnard College.
The Neuroethics Research Unit was created in 2006, at the Institut de recherches cliniques de Montréal (IRCM), which is affiliated to the Université de Montréal. The Unit is one of the pioneer units in Canada in this area of research. Neuroethics is a new area of research where bioethics and neuroscience intersect. The focus is on ethical considerations in neuroscience research and the many ethical issues that arise from the transfer of neuroscience to health care.
The NeuroGenderings Network is an international group of researchers in neuroscience and gender studies. Members of the network study how the complexities of social norms, varied life experiences, details of laboratory conditions and biology interact to affect the results of neuroscientific research. Working under the label of "neurofeminism", they aim to critically analyze how the field of neuroscience operates, and to build an understanding of brain and gender that goes beyond gender essentialism while still treating the brain as fundamentally material. Its founding was part of a period of increased interest and activity in interdisciplinary research connecting neuroscience and the social sciences.
Robyn Bluhm, is associate professor at the Department of Philosophy and Lyman Briggs College, Michigan State University, as well as a member of The NeuroGenderings Network – a group which promotes "neurofeminism". She is the current joint editor of the IJFAB: International Journal of Feminist Approaches to Bioethics
Nita Farahany is an Iranian American author and distinguished professor and scholar on the ramifications of new technology on society, law, and ethics. She is the author of the critically acclaimed book, The Battle for Your Brain: Defending the Right to Think Freely in the Age of Neurotechnology. She currently teaches Law and philosophy at Duke University where she is the Robinson O. Everett Distinguished Professor of Law & Philosophy at Duke Law School, the founding director of the Duke Initiative for Science and Society as well as a chair of the Bioethics and Science Policy MA program. She is active on many committees, councils, and other groups within the law, emerging technology, and bioethics communities with a focus on technologies that have increasing potential to have ethical and legal issues. In 2010 she was appointed by President Obama to the Presidential Commission for the Study of Bioethical Issues.